Hundreds of thousands of patents are expected to be shared freely by Japanese companies such as Toyota, Canon, etc. to other organizations and companies to accelerate the process of discovering treatments for the Covid-19 pandemic around the globe.
According to the Nikkei daily, about 20 Japanese companies, including Toyota and Canon, will issue patents and intellectual property registered in Japan or other countries to help fight the Covid-19 pandemic. .
The goal of the initiative is to enable businesses and research institutions to rapidly develop medical devices and experimental technologies for more effective treatment of this dangerous disease. In addition, companies also hope to have a solution to help quickly quell the crisis affecting the global economy.
The original idea came from the proposal of Professor Fumihiko Matsuda, head of the Genomic Medical Center at Kyoto University. In addition to the above companies, Nissan Motor, Honda Motor, Shimadzu, Ajinomoto Group have also participated in this initiative. The innovators will continue to call for more companies to participate in this initiative.
In principle, all patents, design rights and copyrights owned by each company will be freely distributed to other organizations, companies or manufacturers as long as they are used for research. Covid-19 treatment support equipment. Companies will provide patents and copyrights for free without requiring them until the World Health Organization (WHO) declares the end of the Covid-19 global pandemic.
Several hundred thousand patents are expected to be provided free of charge through this humanitarian initiative.
One of the remarkable patents in the initiative must mention belongs to Toyota. The company’s patent shares technology that collects respiratory data from patients with Covid-19 without contacting them. It was originally developed for use by nursing robots.
If doctors can monitor a patient’s breath in a safer way, they can make it easier to develop a treatment regimen based on the patient’s pneumonia situation. In particular, this technology of Toyota helps limit production costs to the maximum and saves the effort in researching diagnostic machines and medical equipment.
Meanwhile, the small size X-ray equipment of Shimadzu is also of interest. The lungs of patients infected with Covid-19 often have a very characteristic shape due to virus attack. With these compact X-ray devices, hospitals can proactively monitor patients’ health or detect danger signs that require early intervention.
This initiative benefits companies and research organizations that inherit patents. Normally other companies wishing to use a patent will have to negotiate with the owner, but the process usually takes 1-2 years because the final decision-making process is quite long. But with the initiative, patents will be released and used immediately and all completely free, thereby bypassing the time-consuming negotiations. In addition, open patents will also help avoid risks if other companies are unable to use the patent due to failure to reach agreement on copyright fees.
These free patent companies will not receive any benefits, but it is clear that helping the community and joining hands to combat the Covid-19 pandemic is also a way to reduce the impact of the recession. economists to these companies.
Ultimately, the initiative ensures the fastest and simplest access for technology companies through a simplified procedure, including simply downloading documents from a dedicated website.